CURRICULUM VITAE

Name : Dr. Mahmoud Mohamed Ghorab

Nationality: Egyptian

Date of birth: 07-18-1941

Marital status: married, two kids.

Qualification: * Bachelor of Pharmaceutical Sciences (1961), Cairo
University.

* Master of Pharmaceutical Sciences in Pharmaceutics (1966), Cairo university.

* PhD of Pharmaceutical Sciences in Pharmaceutics (1969), Cairo University.

Past experience: *Pharmacist in the ministry of public health (1961).

* Demonstrator in the department of Pharmaceutics, Faculty of Pharmacy, Cairo university, from (1962).

* Lecturer in the department of Pharmaceutics, Faculty of Pharmacy, Cairo university, from (1969).

* Assistant professor in the department of Pharmaceutics, Faculty of Pharmacy, Cairo university, from (1974).

* Visiting professor in the school of pharmacy London university, England, from (1977) to (1978).

* Professor in the department of Pharmaceutics, Faculty of Pharmacy, Cairo university, from (1980).

* Visiting professor in the department of Pharmaceutics, Faculty of Pharmacy, Khartoum university, Sudan in 1981.

* Treasurer of the Egyptian pharmaceutical society, (1987).

* Vice-president of the Egyptian pharmaceutical society, (1988).

* Visiting professor in the college of Pharmacy, Rode Island university, U.S.A. for 9 months in 1989.

* Head of the department of Pharmaceutics and Pharmaceutical Technology, from July (1998) till July (2001).

* Chairman of board of director of the Egyptian Research and Development Company.

Scientific activity: Supervised a lot of Thesis for Master and PhD degrees, in the science of Pharmaceutics and Pharmaceutical Technology, 10 Masters and 7 PhDs.

List of publication: See attached.

List of patents: See attached.

Professional activity: Head of Giza pharmacy Syndicate for two consecutive periods since (1988) till now.

* Advisor of the culture committee in the faculty of pharmacy, Cairo university, from (1966).

* General supervisor of international students in the ministry of high education from (1968-1969)

* Joined military service from (1969) to (1973).

* Participated and lectured in many scientific and professional pharmaceutical conferences, which were held locally and universally.

* Received American fulbright scholarship in 1987.

* Under secretary of promotion committee for professors in the field of Pharmaceutics and Pharmaceutical Technology from (1989), supreme council of university.

* Member of the board of directors (Global Napi drug company) from (1995) till now.

* Consultant of the board of directors (CID drug company) from (1996) till now.

*Consultant of the board of directors (MISR drug company) from (1983) till now.

* Scientific consultant of (Memphis drug company) from (1997) till now.

* Scientific consultant on the construction of the antiseptic department at the Nile pharmaceutical company (2005)

* Consultant of the Egyptian armed forces drug factory (1996) till now.

* Member of the ministry of health committee for auditing and licensing pharmaceutical manufacturing facilities (2006-2009).

* Member of supreme drug committee in the Egyptian health insurance organization.

* Chairman of the scientific committee for promoting professors and associate professors (September 2008 – current)

* Councilor in the police medical academy.

* Lecturing different courses for undergraduate students in the field of pharmaceutics and pharmaceutical technology.

* Teaching different courses for graduate students in the field of industrial, hospital, clinical pharmacy and cosmetics.

* Lecturing different courses for GMP validation, in-process quality control, quality management, quality assurance and total quality assurance for industrial graduates.

* Teaching a course on facility planning, design and construction of pharmaceutical firms.

* Member of the selection committee for professors applying to the American fulbright scholarship, from (1991) till now.

* Member of the supreme court of Ethics from (1995).

* Scientific consultant of pharmatica annual conference and exhibition.

* Head of board of directors and the executive member of ERDC (2001).

* Have three patents applied and commercially marketed in the field of drug industry (Pystinon Tabs - Phyntoin Caps. - Duropin Vials).

* Consultant for Rhon Polanc Rore company from 1996 to 2000).

Languages: English (very good), French (fair)

Address: Work: Faculty of Pharmacy, Cairo university, EI-Kasr EI-Eini street, 11562, Cairo, Egypt.

Residence: Building 11, Abu EI-Maati street, apt. # 104, EI-Balloon, EI-Agoza, Giza, Egypt.

Telephone No.: 00202/3467141, 3473341 and 0124436479.


List of publications and Conference presentations

[1] Hussein, A. M., Kassem, A. A., Tawfik, A. S. and Ghorab, M., "Pharmaceutical Studies of Some Iron Salts of Saccharic Acid"; J. Pharm. Sci. U. A. R., Vol. 3, pp. 105-110 (1969).

[2] Hussein, A., M., Kassem, A., A., Amer, M. and Ghorab, M., "Evaluation of Vitamin B12 in Pharmaceutical Hemopoeitic Preparations"; J. Pharm. Sci. U. A. R., Vol. 3, pp. 311-324 (1969.)

[3] Kassem, A. A., Ghorab, M. and Abd EI-Maksoud, F., "Preparation of Water Repellent Non Adhesive Surgical Dressings"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XI, No.1, pp. 247-258 (1972).

[4] Ghorab. M., Mahrous, H., Geneidi, A. S. and Kassem, A. A., "Sodium Chloride: Design and Study of an Oral and Controlled Release Tablets"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XI, No.1, pp. 259-269 (1972).

[5] Kassem, A. A., Said, S. A., Ghorab, M. and Abd EI-Maksoud, F., "The Use of Silicones in Timica Lip Sticks"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XI, No.2, pp. 163-174 (1972).

[6] Kassem, A. A., Ghorab, M. and Assem, A., "Film Coating of B. Complex Vitamins Tablets"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XI, No.2, pp. 155-162 (1972).

[7] Kassem, A. A. and Ghorab, M., "Controlled Release of Potassium Ions in Dihydrochlorothiazide potassium Chloride Saliuretic Tablets"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. III, No.1, pp. 53-60 (1973).

[8] Kassem, A. A., Ghorab, M. Said, A. A. and Abd EI-Maksoud, F., "Use of Semithicone in Antacid Digestive Medications"; Proc. VIII Conf. Pharm. Sci. Cairo, Egypt, pp. 163-166 (Feb 1974).

[9] Geneidi, A. S., Mahrous, H., Ghorab, M. and Kassem, A. A., "Detection of Aggregates formation in Some Antibiotics Ion Exchange Resin Systems"; Proc. VIII Conf. Pharm. Sci. Cairo, Egypt, pp. 167-170 (Feb 1974).

[10] Kassem, A. A. and Ghorab, M., "Formulation and Preparation of Some Effervescent Granules"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XIV, No.1, pp. 139-145 (1975).

[11] Kassem, A. A., Ghorab, M., EL-Gendy, A. R. and Abd EI-Maksoud, F., " The use of Siliconized Lubricants for the Tablet Manufacture"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XIV, No.2, pp. 231-237 (1975).

[12] EI-Shater, S., Ghorab, M., Zaki, S. and Kassem, A. A., " Formulation and Stability Studies of Piperazine Citrate Solution"; Bulletin of Faculty 'of Pharmacy, Cairo Univ. Vol. XIV, No.2, pp. 215-229 (1975).

[13] EI-Samaligy, M., Ghorab, M. and Kassem, A., "Antacid Efficiency of Magnesium Trisilicate in Presence of Various Polymeric Materials"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XIV, No.1, pp. 147-154 (1975).

[14] Ghorab, M., EI-Samaligy, M. and Kassem, A., "Influence of Siliconization on the Flowability of Certain Mineral Silicates and Drugs"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XIV, No.2, pp. 177-186 (1975).

[15] Abd EI Rehim, A. and Ghorab, M., "Use of Acrylic Resins for the Preparation of Depot Antispasmodic-sedatic Microperle Granulates"; 5th Congo of Arab. Pharma. Union 8-11, No.1, p. 215 (1976).

[16] Ghorab, M., "Kinetic Degradation of Methenamine in Urine and Buffered Solutions"; Ibid, Union 12-15, No.1, p. 221 (1976).

[17] Ghorab, M., "Formulation and Biopharmaceutical Study on Caffeine and Caffeine Sustained Release Preparations"; Ibid, Union 16-19, No.1, p. 227 (1976).

[18] Ghorab, M., "Formulation and Biopharmaceutical Evaluation of Methenamine and Drugs Containing Methenamine"; Ibid. Union 20-23, No.1, p. 233 (1976).

[19] Beckett, A. H. and Ghorab, M., "Evaluation of Different Products of Ammonium Chloride to Control Urinary pH in Humans"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XV, No.1, pp. 120-125 (1976).

[20] Ghorab, M. "Urine Acidifiers, Evaluation and Biopharmaceutical Study"; Ibid. Vol. XV, No.1, pp. 126-130 (1976).

[21] Kassem, A. A., Zaki, S., Ghorab, M., EI-Samaligy, M. and Saleh, S. L., "Degradation Kinetics of Tartar Emetic Solution"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XVI, No.1, pp. 19-26 (1977).

[22] Kassem, A. A., Zaki, S., Ghorab, M., EI-Samaligy, M. and Saleh, S. L., "Stability and Formulation of Tartar Emetic Injectable Solutions"; Bulletin of Faculty of Pharmacy, Cairo Univ. Vol. XVI, No.1, pp. 27-35 (1977).

[23] Kassem, A. A., Ghorab, M. and Assem, M. A., " Formulation and Stability of Lipotropic Tablets"; Ibid, Vol. XVIII, No.1, pp. 75-83 (1978).

[24] EI-Samaligy, M., Ghorab, M. and Abd Elbary, A., "Formulation and Biopharmaceutical Evaluation of Timed Release Aspirin"; XVI Egyptian Conf. of Pharm. Sci., Cairo (1980).

[25] Abd Elbary, A., EI-Samaligy, M. and Ghorab, M., "Bioavailability of Tetracyclin From Different Commercial Brands"; XVI Egyptian Conf. of Pharm. Sci., Cairo (1980).

[26] Ghorab, M. and EI-Samaligy, M., "Evaluation of Nitrofurantoin in Different Pharmaceutical Dosage Forms"; XVI Egyptian Conf. of Pharm. Sci., Cairo (1980).

[27] Ghorab, M., Mansour, F. F. and Afifi, N. N., "Dissolution Profile of Indomethacin from its Various Solid Dispersions"; J. Egypt. Pharm. Sci., Vol. 28, No 1-4, pp. 339-344 (1987).

[28] Ghorab, M., Mansour, F. F. and Afifi, N. N., "Release Characteristics of Indomethacin from its Pellets Coated with Various Release Retardants"; J. Egypt. Pharm. Sci., Vol. 28, No 1-4, pp. 345-352 (1987).

[29] Ghorab, M, Mansour, F. F. and Afifi, N. N., "Bioavailability of Indomethacin from Different Controlled Release Capsule Formulations"; J. Egypt. Pharm. Sci., Vol. 28, No 1-4, pp. 353-360 (1987).

[30] Ghorab, M. M., Kassem, A. A. and Abdel Ganal, N. A.,"Diazepam Injectable Solutions: Formulation and Stability Studies"; Bull. Fac. Pharm. Cairo Univ., No.1, pp. 48-80 (1989)

[31] Ghorab, M., EI-Mahrouki, G. M. and Makky, A. A., "Interactions of Certain Non-steroidal Anti-inflammatory Drugs with Aromatic Amino Acids. 1. Complexation of Indomethacin with Aromatic Amino Acids"; Bulletin of Faculty' of Pharmacy, Cairo Univ., Vol. 28, No.3, pp. 27-30 (1990).

[32] Ghorab, M. M., EI-Mahrouki, G. M. and Makky, A. A., " Interaction of

Certain Non-steroidal Anti-inflammatory Drugs with Aromatic Amino Acids. Interactions with Mefenamic Acid with Aromatic Amino Acid"; Ibid., pp. 31-34

(1990).

[33] Ghorab, M. M., EI-Mahrouki, G. M. and Makky, A. A., "In-vitro and In-Vivo Evaluation of Certain Indomethacin-Aromatic Amino Acid Complexes"; Ibid, pp. 35-39 (1990).

[34] Ghorab, M. M., Zei, H. and Luzzi, L. A., "Preparation of Controlled Release Anti-cancer Agents Flourouracil-ethyl cellulose Microspheres"; J. Microencapsulation, Vol. 7, No.4, pp. 447-454 (1990).

[35] Ghorab, M. M., Mahmoud, H. A. and Afifi, M. M., "In-vitro and In-Vivo Evaluation of Cinnarzine Solid Dispersion"; XXII Conference of Pharmaceutical Sciences of the Egyptian Pharmaceutical Society 17-19 (Dec. 1991 ).

[36] Ghorab, M. M., Mahmoud, H. A. and Afifi, M. M., "Preparation and Biopharmaceutical Evaluation of Kellin Coprecipitates"; Ibid.

[37] Farag, S. I., EI-Shater, S. and Ghorab, M. M., "Flurbiprofen-load Ethocil Microspheres. Preparation and Evaluation"; Ibid.

[38] Farag, S. I., EI-Shater, S. and Ghorab, M. M., "Preparation and Evaluation of Flurbiprofen Solid Dispersion in Various Release Retardants"; Ibid.

[39] Nour, S. A., Abd EI- Hady, S. E. and Ghorab M. M., "A Natural Coloring Agent from Hipiscus Subdarifa, Effect of pH and Vehicle Changes"; Ibid.

[40] Ghorab, M., Hamza, Y. and EI-Assasi, A., "Influence of Certain Eudragits on Sustainment of Ibuprofen Tablets"; Pharmacy World Congress, Washington, D.C., U.S.A., 40-spt-007, Sept. (1991).

[41] Ghorab, M., Hamza, Y. and EI-Assasi, A., "Effect of Polystyrene on Sustainment of Dexropropoxphene HCI Tablets"; FIP, 92 Congress, Lyon, France (Sept. 1992).

[42] Ghorab, M., Hamza, Y. and EI-Assasi, A., "Sustainment of Release of Dextropropoxyphene HCI with Polystyrene Via Microencapsulation Technique"; Ninth International Symposium on Microencapsulation, Lyon, France (Sept. 1992).

[43] Ghorab, M., Ammar, H., EI.,Ridy, M. S. and Ghorab, M. M.," Evalution of the Anti-schistosomal Effect of Praziquentel in a liposomal Delivery Systems in Mice", Intern. J. Pharm. 103, 237 (1994).

[44] Ghorab, M, Tayel, S. and Hussein, S., "Formulation and Evaluation of Rifamycin SV Sodium Eye Drops", 24th Egyptian Conference of Pharmaceutical Sciences, Cairo, Egypt, Dec. (1994).

[45] Ghorab, M, Tayel, S. and Hussein, S., "Formulation and Evaluation of Rifamycin SV Sodium Dermatological Perparations", 24th Egyptian Conference of Pharmaceutical Sciences, Cairo, Egypt, Dec. (1994).

[46] Ghorab, M, Tayel, S., Hussein, S. and Ahmady, A., "Microbiological

Studies of Certain Rifamycin SV Sodium Formulae Prepared For External

Use", 24th Egyptian Conference of Pharmaceutical Sciences, Cairo, Egypt, Dec. (1994).

[47] Ammar, H. O., Ghorab, M., EI-Nahas, S. A. and Ghorab, MM., "Improvement of Some Pharmaceutical properties of Drugs, Part 4. Chloropromazine Hydrochoride; Pharmazie, 50(12) H, 805-808 (1995).

[48] Ammar, H. 0., Ghorab, M., EI-Nahas, S. A. and Ghorab, MM., "Improvement of Some Pharmaceutical properties of Drugs by Cyclodextrin Complexation, Part 5. Theophylline; Pharmazie, 51(1), 42-46 (1996).

[49] Ammar, H. O., Ghorab, M., EI-Nahas, S. A. and Ghorab, MM., "Improvement of Some Pharmaceutical properties of Drugs by Cyclodextrin Complexation, 6. Ampicillin; Pharmazie, 51 (8), 568-570 (1996).

[50] Ammar, H. O., Ghorab, M., EI-Nahas, S. A., Omr, S. M.and Ghorab, M

M., "Interaction of Dicumarol with (3-Cyclodextrin"; Egypt. J- Pharm- Sci., Vol. 37(1-6),431-444 (1996).

[51] Ammar, H. O., Ghorab, M., EI-Nahas, S. A., Omr, S. M.and Ghorab, M

M., "Interaction of Hydrochlorothiazide with (3-Cyclodextrin"; Egypt. J. Pharm. Sci., Vol. 37(1-6), 445-458 (1996).

[52] Badawy, S., Ghorab, M. M. and Adeyeye, C. M., "Bioavailability of Danazol-Hydroxypropyl-b-Cyclodextrin Complex by Different Routes of Adminstration"; Int. J. Pharm., 145, 137-143 (1996).

[53] Badawy, S., Marshall, M., Ghorab, M.M. and Adeyeye, C.M., "Evaluation of Sulfobutylether Derivatives of Cyclodextrins as Solubility and Dissolution Enhancers of Danazol", Drug Develop. Ind. Pharm., August (1996).

[54] Ammar, H. O., Ghorab, M., EI-Nahas, S. A. and Makram, T. S., "Interaction of Oral Anticoagulant with Methyl Xanthines; Pharmazie, 52(12), 946-950 (1997).

[55] Ammar, H. 0., Ghorab, M., EI-Nahas, S. A. and Makram, T. S., "Improvement of the Biological Performance of Oral Anticoagulant Drugs, Part 2, Dicumarol"; Pharmazie, 52(9), 727 (1997).

[56] Ammar, H. 0., Ghorab, M., EI-Nahas, S. A. and Makram, T. S., "Improvement of the Biological Performance of Oral Anticoagulant Drugs, Part 1. Warfarin"; Pharmazie, 52(8), 627-631 (1997).

[57] Ghorab, M. M., Afifi, N. N. and Makky, A. M., "Formulation and Pharmaceutical Evaluation of Sulindac Suspensions"; XXV Conf. of Egypt. Pharm Sci., (Dec. 1998).

[58] Ghorab, M. M., Afifi, N. N., Makky, A. M. and Abd EI-latif, "Further Evaluation of Certain Sulindac Suspensions"; XXV Conf. of Egypt. Pharm Sci., (Dec. 1998).